You are here

Article Text

Article menu
Download PDFPDF
Evidence-based medicine
Etomidate had shorter induction and recovery times than midazolam for fracture reduction

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In children and adolescents presenting with a displaced extremity fracture who require sedation, does etomidate show faster onset and recovery than midazolam?

    Di Liddo L, D'Angelo A, Nguyen B, et al. Etomidate versus midazolam for procedural sedation in pediatric outpatients: a randomized controlled trial. Ann Emerg Med 2006;48:433â40.

    Clinical impact ratings Emergency medicine âââââââ Paediatrics (general) âââââââ

    METHODS

    Embedded ImageDesign:

    randomised controlled trial.

    Embedded ImageAllocation:

    concealed.*

    Embedded ImageBlinding:

    blinded (patients, investigators, {data collectors, outcome assessors, and data analysts}†).*

    Embedded ImageFollow up period:

    up to discharge.

    Embedded ImageSetting:

    emergency department (ED) of a tertiary care paediatric hospital.

    Embedded ImagePatients:

    100 patients 2–18 years of age (mean age 8.7 y, 50% boys) who presented to the ED with a displaced extremity fracture requiring sedation and analgesia for closed reduction. Exclusion criteria included respiratory tract infection, haemodynamic instability, recent head injury, known seizure disorder, heart or lung disease, craniofacial anomaly, adrenocortical dysfunction, …

    View Full Text

    Footnotes

    • Source of funding: Fonds d’opération pour les projects de recherche de l’Hôpital Ste-Justine.

    • Reproduced with permission from Evidence-Based Medicine 2007;12:77